TGF-β signaling plays a dual role in NSCLC acting as a tumor suppressor in early disease stages by inhibiting proliferation but being pro-metastatic in advanced disease by inducing EMT and immune evasion [54,55]. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.